Topic List : Cancer
Next generation of CAR-T cells possible
CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.
Protein decoy stymies lung cancer in mice
Researchers at Stanford and UCSF slowed the spread of a type of nonsmall cell lung cancer in mice by neutralizing a single protein that would otherwise set off a chain reaction, causing runaway tumor growth.
Identifying who benefits from chemo drug
Anthracyclines can be effective against breast cancer but often have toxic side effects. Stanford researchers used gene expression levels to identify women most likely to benefit from the drugs, regardless of breast cancer type or stage.
Tanning salons cluster in gay neighborhoods
Neighborhoods with more gay and bisexual men are twice as likely to have indoor tanning salons, Stanford researchers have found. Further research is needed to learn whether the industry specifically targets this population.
Cancer-drug combo extends life about 9 months
The results of a phase-3 clinical trial led by a Stanford researcher showed that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with a common type of metastatic breast cancer.
Brain tumors integrate in neural wiring
Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a Stanford study has found.
Chair of epidemiology and population health named
Melissa Bondy has been appointed chair of the Department of Epidemiology and Population Health and associate director for population sciences at the Stanford Cancer Institute.
Irving Weissman honored for stem cell, cancer work
Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.
No chemo for some with leukemia
A large multicenter clinical trial led by Stanford physician Tait Shanafelt, MD, indicates that people with chronic lymphocytic leukemia may forgo chemotherapy in favor of new, targeted treatments.
New ‘don’t eat me’ signal discovered
Cancer cells are known to protect themselves using proteins that tell immune cells not to attack them. Stanford researchers have discovered a new “don’t eat me” signal, and blocking it may make cancer cells vulnerable to attack by the immune system.